NCT01048034 2013-10-29Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)Nordic MDS GroupPhase 2 Completed30 enrolled
NCT01222195 2012-08-07Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)M.D. Anderson Cancer CenterPhase 2 Terminated1 enrolled 5 charts